New requirements for clinical testing of vaccines, announced this month, may delay the availability of shots that had formerly been updated annually without complicated trials.

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust make it challenging to craft effective public health responses.

WASHINGTON (AP) — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.

The rising coronavirus cases once again in many parts of the world, especially in Asian countries (such as Hong Kong and Singapore), have raised concerns for health experts. Recent reports show that there has been a sharp increase in coronavirus cases here for the last few weeks.

The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump administration has introduced uncertainty into the annual process for green-lighting updated coronavirus shots traditionally offered in the fall.

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the development of the company’s Covid-19 vaccine was purposefully delayed until after the 2020 presidential election.

A new report says Health and Human Services Secretary Robert F. Kennedy Jr. will roll back current CDC guidance on COVID vaccinations for pregnant women and children.

Another Breakthrough Summit West in the books, and what an excellent event! We kicked off the day with former FDA head Robert Califf, who stopped by to tell attendees how health secretary Robert F. Kennedy’s hesitance to endorse vaccines is harming the American public.